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Abstract 
Formal, computer-interpretable representations of 
eligibility criteria would allow computers to better 
support key clinical research and care use cases such 
as eligibility determination. To inform the 
development of such formal representations for 
eligibility criteria, we conducted this study to 
characterize and quantify the complexity present in 
1000 eligibility criteria randomly selected from 
studies in ClinicalTrials.gov. We classified the 
criteria by their complexity, semantic patterns, 
clinical content, and data sources.  Our analyses 
revealed significant semantic and clinical content 
variability. We found that 93% of criteria were 
comprehensible, with 85% of these criteria having 
significant semantic complexity, including 40% 
relying on temporal data. We also identified several 
domains of clinical content. Using the findings of the 
study as requirements for computer-interpretable 
representations of eligibility, we discuss the 
challenges for creating such representations for use 
in clinical research and practice. 
Introduction and Background 
Clinical trials are one of the most valuable sources of 
evidence on the efficacy of treatments in humans. 
Evidence based medicine seeks to apply findings 
from clinical trials to better evaluation and treatment 
in clinical populations across all domains of 
medicine. Aside from a JAMA study that examined 
the prevalence of exclusion criteria in excluding 
Women, children, the elderly, and those with 
common medical conditions from trials, however, 
there has never been a formal study of the semantic 
and syntactic features and of the complexity of 
eligibility criteria1. What is needed is a clear 
specification of the kinds of subjects studied in a trial, 
i.e., the clinical phenotype studied, to facilitate data 
pooling and the application of pooled and study-
specific results to individual patients or to 
populations.   
While disease diagnosis (e.g. ICD-9) is often used as 
a stand-in for clinical phenotype, clinical phenotypes 
used in clinical studies are much more complex than 
can be captured in an ICD term. The phenotypes 
studied are often refined by their severity, associated 
complications, or response to specific treatments 
(e.g., labile Type II diabetes requiring insulin 
treatment). These complex phenotypes are explicitly 
stated in the eligibility criteria for the trial. In fact, the 
aggregate set of eligibility criteria for any one trial 
defines the overall clinical phenotype of the 
population being studied in the trial. Each trial may 
have dozens of eligibility criteria, and each criterion 
may be extremely complex, in terms of both grammar 
and content. 
Several groups have created formal representations of 
eligibility criteria, which include CDISC’s ASPIRE2, 
Arden Syntax3, SAGE4, and GELLO5.  In related 
work, our Trial Bank Project team at UCSF has 
developed the Eligibility Rule Grammar and 
Ontology (ERGO) and its related formalism ERGO 
Annotation to standardize complex clinical 
phenotype descriptions as “templates” that, when 
combined with terms from ontologies and 
standardized vocabularies, can reproducibly describe 
phenotypes in a generic computable representation6. 
The evaluation and development of eligibility criteria 
representations would be greatly assisted by an 
understanding of the types and range of clinical and 
semantic features commonly seen in eligibility 
criteria. To our knowledge, however, there has never 
been a formal study of the semantic and syntactic 
features and the complexity of eligibility criteria. The 
goal of this study is to analyze a large number of 
randomly chosen eligibility criteria from actual trials 
across all clinical domains, to characterize the range 
and types of complexities present, and to identify 
common semantic patterns. 
Materials and Methods 
On December 30, 2003, we downloaded all studies in 
ClinicalTrials.gov as a collection individual XML 
files (n=9117), of which 1000 were randomly 
selected for this study. We extracted the text of these 
criteria, without any metadata (e.g., designations as 
“exclusion” or “inclusion” criteria, or clinical domain 
of study) because we were analyzing only the 
semantic and clinical content in the criteria 
themselves (available in Supplementary Materials).  
We imported the criteria into an Excel spreadsheet 
and analyzed them by hand (JR) for their content and 
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semantic structure. Initially we designated criteria as 
“comprehensible and selective” or “incomprehensible 
or non-selective.” We designated criteria as 
“comprehensible and selective” if their logic was 
readily apparent and effectively defined potential 
subjects as eligible or ineligible for the study (i.e., 
stated an allowed or disallowed phenotype). These 
criteria may have had minor grammatical or spelling 
errors that did not compromise the underlying logic, 
and are referred to in the remainder of this text as 
Comprehensible and Selective Eligibility 
Criteria(C&S criteria). We designated criteria as 
“incomprehensible or non-selective” if they were 
truncated or otherwise nonsensical, or if they did not 
define a phenotype (e.g., the statement “History of 
breast cancer allowed” does not describe a phenotype 
to be excluded or included in the study and is 
therefore non-selective). We recorded the reasons that 
criteria were classified as “incomprehensible” or 
“non-selective.” 
C&S criteria were then classified along several axes. 
First, they were designated as “simple” or “complex.”    
Simple criteria were those consisting of a discrete 
clinical concept expressed as a single phrase (e.g. 
lung cancer, anemia, uncontrolled hypertension) or its 
negation (not pregnant), or a simple quantitative 
comparison (e.g., WBC > 5000 cells/mm3). If we 
were able to rewrite a criterion as a simple criterion 
by omitting a modifier or modifiers without changing 
the meaning of the criterion, it was counted as simple 
(e.g., “No uncorrected hypokalemia” was rewritten to 
“No hypokalemia”, the simple negation of a noun 
phrase). All other criteria were deemed to be complex 
criteria. 
The second axis of classification for the criteria was 
by their high-level clinical content, i.e., whether the 
criterion concerned: 1) a clinical attribute of the study 
participant (e.g., a symptom, a disease), 2) a 
treatment or intervention on the participant, or 3) a 
behavior of the participant. These three categories 
were defined after preliminary examination of criteria 
suggested them to be mutually exclusive and 
exhaustive in covering the high-level clinical content 
of all eligibility criteria. 
After classification of criteria by their complexity and 
their high-level clinical content, we analyzed the 
criteria for semantic and clinical patterns and tallied 
the proportion of their presence. We identified and 
tallied the broad semantic patterns according to the 
following heuristics.  
1. Boolean criteria include those with AND and OR 
connectors, or parentheses, commas, “/”, or other 
grammatical proxies for AND and OR. If a 
“with” could be converted to an AND without 
any loss of information (e.g., “Cirrhosis with a 
history of ascites” was rewritten to “Cirrhosis 
AND a history of ascites”), the criterion was 
counted as ‘Boolean’. 
2. Partially specified lists were treated as OR 
statements including each element of the list and 
therefore designated as Boolean(e.g.“History of 
cardiac disease (e.g. MI, CHF))” was expanded 
to “History of cardiac disease OR MI OR CHF. 
3. Phrases with connectors “without”, “except”, 
“unless”, and “other than” were counted as 
‘exclusion connectors’. 
4. Criteria with semantic connectors commonly 
used in clinical eligibility criteria, including  
“caused by”,  “defined by“, and “documented 
by”, “diagnosed by”, and “confirmed by” were 
tallied as ‘delimiting connectors’. 
5. Phrases were counted as having ‘temporal 
connectors’ if they contain temporal descriptors 
or comparators (e.g. “at least 3 times per week”), 
or references to temporal events during the study 
(e.g., “at hospital discharge”). 
6. Criteria that could be rewritten as “if then” 
statements were counted as ‘If then’ statements 
(e.g., “Prior sentinel node biopsy allowed 
provided nodes are pathologically negative” was 
rewritten to “If prior sentinel node biopsy then 
nodes are pathologically negative”). 
7. C&S criteria were counted as ‘able to be reduced 
to simple criteria’ if they could be decomposed 
into only simple statements through Boolean, 
if..then, or exclusion decomposition(e.g. No 
history of CHF and CAD can be broken down 
into the two simple rules: “No history of CHF” 
AND “No history of CAD”). 
Furthermore, we identified patterns of clinical 
content and tallied the proportion of their presence:  
1. Criteria pertaining to demographic data. 
2. Criteria that refer to informed consent or a 
participant’s willingness to adhere to protocol 
requirements (e.g., return for follow up). 
3. Criteria pertaining to laboratory and other test 
results and other quantitative data, including 
stages,, grades or other standardized clinical 
scales. Also included in this group were criteria 
containing references to arithmetic “normal 
values” (e.g. AST > 4 x Upper Limit of Normal). 
4. Temporally related criteria. These included 
criteria having temporal connectors and 
comparators, and ranged from criteria that 
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clearly referred to an attribute, intervention or 
behavior that was present at the “start of the 
study”, to criteria that refer to “within the past 6 
months”, to criteria that refer to “prior” or 
“concurrent” attributes, interventions or 
behaviors without any further specifications We 
distinguished three subtypes of temporally 
related criteria:  
a) Well specified temporal criteria -- These 
criteria listed a clear time period with reference 
to a discrete date (e.g. study day 1, the day the 
patient received treatment). 
b) Moderately specified temporal criteria -- 
These criteria listed a clear time period, but with 
no reference to study dates (e.g., within the last 6 
months, within the prior 2 weeks), 
c) Loosely specified temporal criteria -- These 
criteria mainly used "prior" or "current" as 
temporal specifiers. 
5. Criteria that implicitly require clinical judgment, 
the details of which are not specified, but that the 
average clinician would understand and find 
meaningful  (e.g., “eligible for statin therapy”). 
6. Criteria that require information beyond the 
criterion itself, e.g. from study meta-data or other 
criteria (e.g. “No evidence of metastases” 
without specifying the type of primary 
carcinoma).  
In addition to classifying our test criteria as above, 
we also reviewed the expressiveness of CDISC’s 
ASPIRE, Arden Syntax, SAGE and GELLO to 
represent the eligibility criteria patterns detected in 
this study. 
Results 
Criteria were first divided into those that were 
comprehensible (C&S criteria) and those that were 
not (Table 1). The vast majority of criteria (93%) 
were C&S criteria. Table 1 also describes the 
proportion of criteria classified as incomprehensible 
due to three main reasons. 
Approximately 15% of the C&S criteria were either 
simple statements or could be rewritten as such 
(Table 2). Many of these included negation or simple 
arithmetic comparisons. The remaining 85% of the 
criteria were designated as “complex” and included a 
variety of semantic patterns, including 35% with 
more than one type of the complex semantic patterns 
listed. However, 8% of these C&S criteria could be 
rewritten into two or more simple statements through 
Boolean, if..then, and exclusion decomposition.  
The high-level clinical content of all C&S 
criteria(Table 3)  referred to patient clinical attributes 
71% of the time. Criteria specifying treatments or 
other interventions accounted for 27% of the criteria, 
and criteria referring to patient behavior occurred 2% 
of the time. Criteria containing at least two types of 
clinical content accounted for 7% of the total. 
 
 
Table 1.Comprehensibility of Randomly 
Selected Eligibility Criteria 
Total Eligibility Criteria 1000 (100%) 
Comprehensible Criteria (C&S 
criteria) 
932 (93.2 %) 
Incomprehensible Criteria 68(6.8%) 
Reasons Incomprehensible 
   1.Incomplete Statement 
   2.Doesn’t exclude subjects 
   3.Other 
  
 32/68 (47%) 
 31/68 (46%)     
   5/68 (7%) 
 
Table 2. Semantic Complexity and Variation in 
CSEC  (N = 932) 
Simple Criteria (SC)  
Proportion of CSEC 139/932 (15%) 
SC with negation 21/139 (15%) 
SC with arithmetic comparator 49/139 (35%) 
Complex Criteria (CC) 
Proportion of CSEC 793/932 (85%) 
CC  with  negation 205/793 (26%) 
CC with arithmetic comparator  113/793 (14%) 
CC with Boolean connector 423/793 (53%) 
CC with exclusion connector  25/793(3%) 
CC with defining connector  45/793 (6 %) 
CC with temporal connector 371/793 (47%) 
CC with if…then statement 80/793 (10%) 
CC with 2 or more of the above 
complex semantic patterns  
280/793 (35%) 
CC that can be reduced to SC 
through decomposition 
64/793 (8%) 
 
Table 3. Clinical Content Variation 
1.C&S criteria specifying patient 
clinical Attributes 
659/932(71%
) 
2.C&S criteria specifying 
treatments or interventions 
participant has received or will 
receive. 
314/932(34%
) 
3.C&S criteria specifying patient 
behavior. 
35/932(4%) 
4. C&S criteria including at least 
2 of above 3 types of content. 
72/932(8%) 
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Table 4 shows detailed findings of clinical patterns in 
C & S criteria. Demographic criteria, including age 
and sex, were found in 2.5%,  and  3% pertained to  
informed consent, or to a participant’s willingness 
and ability to participate as specified in the study 
protocol. 
Approximately 23% of the criteria specified the 
results of laboratory tests, other studies, and 
standardized diagnostic criteria, which ranged from 
requiring a very specific numerical value for a 
participant to meet the criteria of the study, to criteria 
that referred to “normal” values (e.g. “AST < Upper 
Limit of Normal”).  
Temporally related features were present in 40% of 
C&S criteria.  In approximately 1/3 of these, the 
timing of clinical assessments, interventions or 
behaviors were well to moderately well defined in 
relationship to the start of the study. In the remainder 
of these criteria, timing was much less precisely 
specified (e.g., clinical assessments or interventions 
“prior” to the study, or happening “concurrently”).  
Another 19% of criteria depended on the clinical 
judgment of a clinician (e.g. “No other medical or 
psychiatric illness that would preclude study 
compliance”) without giving specific indications as to 
how this assessment should be made. Finally, 
approximately 24% of the criteria relied on details of 
the particular study that were not available from 
analysis of the criterion by itself (e.g. “No evidence 
of metastatic disease” without an indication of the 
primary cancer). 
Discussion 
Our analysis of 1000 eligibility criteria randomly 
drawn from ClinicalTrials.gov demonstrates 
significant semantic and clinical variability across 
criteria. This variability presents challenges to 
informaticians, researchers, and clinicians.  The good 
news for informaticians designing expression 
languages is that 23% of C&S criteria are simple 
criteria, or can be reduced to simple criteria through 
Boolean , exclusion, and if-then decomposition. On 
the other hand, 77% of C&S criteria remain complex 
to evaluate as they contain one or more of the 
following patterns: 9% of complex criteria involve 
the use of semantic connectors which are not 
captured by the current representation languages or 
coded data, 40% require the definition of temporal 
constraints (many of which are only loosely 
specified), 19% require clinical judgment, and 24% 
require linkage to study metadata. Researchers trying 
to determine patient eligibility for studies face 
incomprehensible and ambiguous criteria as well as 
under-specified criteria requiring clinical judgment or 
assessments. Furthermore, 7 % of criteria require 
radiographic, histologic, or EKG data that may not be 
available in coded format in the EHR. Automation of 
screening based on these criteria may require natural 
language processing of narrative documents, with 
attendant problems of sensitivity and specificity. 
Clinicians seeking to determine if a study’s 
population is similar to their own patients are equally 
challenged to understand just what clinical phenotype 
was studied in a given trial. 
In this work, we conceptualize the clinical domain 
referenced in eligibility criteria to be orthogonal to 
the criteria’s form (e.g., Boolean combination) and 
data sources (e.g., laboratory test results). We aimed 
to classify criteria in a manner that would be useful 
across clinical domains, to drive development of 
domain-independent eligibility criteria 
representations that will allow for tools and 
discoveries made in one domain to be applied to all 
areas of medicine, including facilitating the 
automation of matching potential subjects to trials, 
designing trials to expand on findings from prior 
Table 4.  Details of Clinical Content 
Variation in C&S criteria(N = 932) 
C&S criteria pertaining to Demographic 
Data       (N = 24/932,  2.5%) 
C&S criteria pertaining to Patient Abilities 
and Informed Consent (N = 28/932,  3%) 
C&S criteria with Labs, Studies, and 
Standardized Diagnostic Criteria (N = 
219/932, 23%) 
C&S criteria with Serum or Urine Lab 
tests 
7% 
C&S criteria with Radiographic Data 1% 
C&S criteria with other lab tests(e.g. 
Echo, EKG, histology, vital signs) 
6% 
C&S criteria with accepted clinical 
diagnostic criteria(e.g. stages and 
grades) 
5% 
C&S criteria with labs requiring 
clinical interpretation(e.g. AST > 4 X 
ULN) 
4% 
C&S criteria with Temporally Related 
Features  (N = 371/932, 40%) 
Well specified temporal C&S criteria 4% 
Moderately specified temporal C&S 
criteria 
11% 
Loosely specified temporal C&S 
criteria 
25% 
C&S criteria requiring Clinical Judgement              
(N = 174/932, 19%) 
C&S criteria dependent on Study Metadata              
(N = 221/932, 24%) 
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studies, and pooling data across studies for meta-
analysis. A disease-specific representation format 
based on data elements and their values, such as that 
of the ASPIRE project, cannot satisfy the expressivity 
requirements revealed in this study. Domain-
independent languages with composition capability, 
such as Arden Syntax, SAGE and GELLO, do not 
have this limitation. 
Additionally, criteria requiring referencing external 
sources, and those based on ill-defined criteria 
provide obstacles to the automation of clinical tasks 
across medical domains. Such criteria have to be 
disambiguated, de-abstracted, and operationalized in 
terms of available data. Work on these issues will 
benefit from an interdisciplinary approach in 
designing ontologies and data structures that allow 
access not only to current sources of quantitative 
laboratory data, but also to high-throughput and 
imaging data that will one day be used regularly in 
clinical practice. 
One strength of our study is that we analyzed 
eligibility criteria without restriction to clinical 
domain.  This method likely produced a wider range 
of variance in criteria than if we had restricted our 
analysis to specific domains, but is more reflective of 
the true range of complexity in eligibility criteria. 
Researchers in a specific field may use criterion 
patterns that are not used in other fields, but we 
abstracted common semantic patterns and our 
categories covered all patterns seen in our sample of 
1000 criteria.   
A limitation of this study is that all of the criteria we 
analyzed were taken from ClinicalTrials.gov, which 
may produce a bias towards criteria from the types of 
trials found in this database, e.g., more quantitative 
than qualitative. Other biases may include more well 
formed eligibility criteria because trials registered in 
ClinicalTrials.gov may be of higher study design 
quality than unregistered trials. Finally, eligibility 
criteria reported to ClinicalTrials.gov may be 
simplified versions of more detailed eligibility 
criteria in actual study protocols.  Our categorization 
of complexity and clinical and semantic patterns will 
need to be tested against criteria extracted directly 
from study protocols to demonstrate its full 
applicability. 
Given the diversity of these criteria, including 
incomprehensible and ill defined criteria, it may well 
be advantageous to consider the formation of clear 
standards for clinical researchers to follow when 
writing eligibility criteria. Our work provides an 
initial framework for considering best practices for 
expressing the clinical and semantic content of 
criteria. While best practice criteria may be viewed as 
initially burdensome, we believe that the benefits of 
having more clearly written criteria will far outweigh 
the costs, and will facilitate formalization and optimal 
use of these criteria as specific phenotypes 
throughout clinical research and care across all 
domains of medicine.  
Conclusions and Future Directions 
There is significant variation in both the content and 
semantic structure of eligibility criteria in clinical 
trials. Evaluations of how current formal 
representations handle the categories of clinical and 
semantic patterns we have documented will help 
move the field forward. We believe this 
characterization of eligibility criteria complexity will 
also help future research on the development of 
formalized representations to capture criteria, as well 
as the automated parsing of criteria into these 
formalized representations for computational support. 
Advances in generic formal representations of 
eligibility criteria will provide the necessary semantic 
foundation for maximizing the ability of computers to 
help manage and apply complex clinical phenotypes 
as defined by eligibility criteria in clinical research.   
Supplementary Materials 
http://rctbank.ucsf.edu/home/ecanalysis.html. 
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